Quantcast

Latest Bare-metal stent Stories

2010-05-05 08:50:00

WALTHAM, Mass., May 5 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis. In its peak sales month, Xience V was used in over 50% of drug-eluting stent procedures, and averaged a unit share of just less than 40% for the first...

2010-05-05 11:52:40

Patients who can postpone non-cardiac surgery for at least six weeks after receiving a coronary stent are less likely to suffer reduced blood flow to the heart, heart attack and death than those who have surgery sooner.

2010-03-10 07:30:00

NATICK, Mass., March 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta.

2010-02-11 22:26:00

DALLAS, Feb. 11 /PRNewswire-USNewswire/ -- Volunteers and staff of the American Heart Association extend their thoughts and well wishes to former President Bill Clinton upon the reports that he has undergone a procedure to insert stents to widen narrowed coronary arteries.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related